Vervolg zonder link opsomming

• About MEB
• Human Medicines
• Veterinary Medicines
• Novel Foods

• News
• Comprehensible package leaflets
• Medicinal Products
  • Marketing Authorisation
  • Package leaflets
  • Allergy information
  • Paediatric medicinal products
  • Generic
  • Biosimilar
  • Off-label-use
  • Public Assessment Reports
  • Prescription or non-prescription
• Pharmacovigilance
  • Reporting adverse events
  • Direct healthcare professional communications (DHPCs)
  • Periodic Safety Update Reports (PSURs)
  • Risk Management Plan (RMP)
  • Pharmacovigilance Working Party (PhVWP)
  • Pregnancy Prevention Programme (PPP)
• Regulatory Affairs
  • eSubmission
  • Package leaflets, SPC and labelling
  • Compassionate use programme
  • Generic medicinal products
  • Good manufacturing practice (GMP)
  • Marketing authorisation via centralised procedure
  • Marketing authorisation via Decentralised and Mutual Recognition procedures
  • Marketing authorisation via National Procedure
  • Specific product categories
  • Products & fees 2011
  • Forms
  • Variations
  • Class labelling (new)
  • Legislation & guidelines
  • Over-the-counter medicinal products
• Homeopathy
  • Assessments
  • Side effects
  • Package leaflets, SPC and labelling
  • Dossier advice
  • Homeopathic Drug Master File (HDMF)
  • Register
  • Legislation
  • Public assessment reports on homeopathy
• CBG-portal
• Consumers
  • Medicines information for consumers
  • Organisation around medicines
  • Meeting with patient and consumer organisations
  • Where can I find information about medicines?
• Herbal Medicinal Products
  • Assessments
  • Package leaflets
  • Register
• Publications
• Medical devices
  • Procedure & dossier requirements
  • Fees
• Database human medicines
• Scientific advice
• Frequently Asked Questions

Back